BDSI Biodelivery Sciences International Inc

Price (delayed)

$3.65

Market cap

$359.72M

P/E Ratio

14.6

Dividend/share

N/A

EPS

$0.25

Enterprise value

$321.82M

Sector: Healthcare
Industry: Biotechnology

Highlights

Biodelivery Sciences International's quick ratio has soared by 59% YoY
The price to earnings (P/E) is 55% lower than the last 4 quarters average of 32.3
Biodelivery Sciences International's debt has increased by 34% YoY
BDSI's EPS is down by 3.8% QoQ

Key stats

What are the main financial stats of BDSI
Market
Shares outstanding
98.55M
Market cap
$359.72M
Enterprise value
$321.82M
Valuations
Price to earnings (P/E)
14.6
Price to book (P/B)
3.38
Price to sales (P/S)
2.32
EV/EBIT
9.35
EV/EBITDA
7.68
EV/Sales
2.02
Earnings
Revenue
$159.21M
EBIT
$34.43M
EBITDA
$41.9M
Free cash flow
$29.38M
Per share
EPS
$0.25
Free cash flow per share
$0.29
Book value per share
$1.08
Revenue per share
$1.58
TBVPS
$1.86
Balance sheet
Total assets
$242.13M
Total liabilities
$133.28M
Debt
$78.54M
Equity
$108.85M
Working capital
$131.56M
Liquidity
Debt to equity
0.72
Current ratio
3.41
Quick ratio
3.02
Net debt/EBITDA
-0.9
Margins
EBITDA margin
26.3%
Gross margin
84.3%
Net margin
16.3%
Operating margin
21.6%
Efficiency
Return on assets
11.2%
Return on equity
26.1%
Return on invested capital
36.3%
Return on capital employed
18.4%
Return on sales
21.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BDSI stock price

How has the Biodelivery Sciences International stock price performed over time
Intraday
2.53%
1 week
14.78%
1 month
6.73%
1 year
-16.09%
YTD
-13.1%
QTD
-6.65%

Financial performance

How have Biodelivery Sciences International's revenue and profit performed over time
Revenue
$159.21M
Gross profit
$134.29M
Operating income
$34.43M
Net income
$25.98M
Gross margin
84.3%
Net margin
16.3%
Biodelivery Sciences International's operating margin has soared by 154% YoY and by 2.4% from the previous quarter
The company's gross profit rose by 26% YoY
Biodelivery Sciences International's revenue has increased by 23% YoY
Biodelivery Sciences International's operating income has increased by 4.4% from the previous quarter

Growth

What is Biodelivery Sciences International's growth rate over time

Valuation

What is Biodelivery Sciences International stock price valuation
P/E
14.6
P/B
3.38
P/S
2.32
EV/EBIT
9.35
EV/EBITDA
7.68
EV/Sales
2.02
The price to earnings (P/E) is 55% lower than the last 4 quarters average of 32.3
BDSI's EPS is down by 3.8% QoQ
The price to book (P/B) is 73% lower than the 5-year quarterly average of 12.5 and 20% lower than the last 4 quarters average of 4.2
BDSI's equity is up by 42% YoY
BDSI's P/S is 36% below its 5-year quarterly average of 3.6 and 14% below its last 4 quarters average of 2.7
Biodelivery Sciences International's revenue has increased by 23% YoY

Efficiency

How efficient is Biodelivery Sciences International business performance
BDSI's ROS has soared by 154% YoY and by 2.4% QoQ
The company's return on invested capital has surged by 104% YoY but it fell by 4.7% QoQ
BDSI's return on equity is down by 7% since the previous quarter
The company's return on assets fell by 3.4% QoQ

Dividends

What is BDSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BDSI.

Financial health

How did Biodelivery Sciences International financials performed over time
The total assets is 82% greater than the total liabilities
Biodelivery Sciences International's quick ratio has soared by 59% YoY
The current ratio has soared by 56% YoY
Biodelivery Sciences International's debt is 28% lower than its equity
BDSI's equity is up by 42% YoY
Biodelivery Sciences International's debt has increased by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.